title: Blepharospasm: an uncommon adverse effect caused by long-term administration of olanzapine.
abstract: BACKGROUND
  Blepharospasm is one of the components of drug-induced Meige's syndrome which is reported to be caused by typical antipsychotics. Reports of blepharospasm or Meige's syndrome caused by atypical antipsychotics are rare.
  
  
  METHODS
  A 30-year-old female patient presented to psychiatry out patient department (OPD) with chief complaints of inability to keep her eyes open for long and excessive blinking for 2 months, irritation of eyes, watery discharge from eyes and photophobia for last 1 month. The patient had been taking olanzapine 10 mg, sertraline 100 mg and divalproex sodium 500 mg per orally on once a day basis for the management of major depressive disorder with psychotic features for last 6 months. Routine blood analysis, thyroid function, EEG, MRI, lipid profile did not reveal any abnormality. Ocular examination was also within normal limits. Olanzapine was suspected as a culprit for the above symptoms of patient, so it was replaced with quetiapine 25 mg/day. Patient showed partial recovery of symptoms within 1 week and complete recovery within 2 months of stopping olanzapine. Causality of olanzapine-induced blepharospasm as per WHO-UMC scale was probable.
  
  
  CONCLUSIONS
  Olanzapine (atypical antipsychotics) should also be kept in the list of suspected drugs causing blepharospasm in psychotic patients on treatment although further similar evidences from observational studies and/or reports are needed to establish the causal relationship.
authors.forename: Tarun
authors.initials: T
authors.lastname: Arora
authors.forename: Vikas
authors.initials: V
authors.lastname: Maharshi
authors.forename: Harmeet S
authors.initials: HS
authors.lastname: Rehan
authors.forename: Pravesh
authors.initials: P
authors.lastname: Nagar
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D001764:Blepharospasm / Q000139:chemically induced* / Q000175:diagnosis*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D000077152:Olanzapine; D013997:Time Factors
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine